Elsevier

Atherosclerosis

Volume 255, December 2016, Pages 43-53
Atherosclerosis

Talin and vinculin are downregulated in atherosclerotic plaque; Tampere Vascular Study

https://doi.org/10.1016/j.atherosclerosis.2016.10.031Get rights and content

Highlights

  • Talin and vinculin are downregulated in atherosclerotic plaques in all arterial beds.

  • Expression of talin-1 in plaque is severely downregulated close to vessel lumen.

  • Talin-2 expression in left internal thoracic artery shows a gradient towards vessel lumen which is absent in the plaque.

  • Talin and vinculin expression may be further reduced in with progression of the disease.

  • Talin and vinculin downregulation in atherosclerotic plaque causes tissue disorganization.

  • Talin and vinculin downregulation may lead to reduced tolerance against mechanical impacts and impaired healing processes.

Abstract

Background and aims

Focal adhesions (FA) play an important role in the tissue remodeling and in the maintenance of tissue integrity and homeostasis. Talin and vinculin proteins are among the major constituents of FAs contributing to cellular well-being and intercellular communication.

Methods

Microarray analysis (MA) and qRT-PCR low-density array were implemented to analyze talin-1, talin-2, meta-vinculin and vinculin gene expression in circulating blood and arterial plaque.

Results

All analyzed genes were significantly and consistently downregulated in plaques (carotid, abdominal aortic and femoral regions) compared to left internal thoracic artery (LITA) control. The use of LITA samples as controls for arterial plaque samples was validated using immunohistochemistry by comparing LITA samples with healthy arterial samples from a cadaver. Even though the differences in expression levels between stable and unstable plaques were not statistically significant, we observed further negative tendency in the expression in unstable atherosclerotic plaques. The confocal tissue imaging revealed gradient of talin-1 expression in plaque with reduction close to the vessel lumen. Similar gradient was observed for talin-2 expression in LITA controls but was not detected in plaques. This suggests that impaired tissue mechanostability affects the tissue remodeling and healing capabilities leading to development of unstable plaques.

Conclusions

The central role of talin and vinculin in cell adhesions suggests that the disintegration of the tissue in atherosclerosis could be partially driven by downregulation of these genes, leading to loosening of cell-ECM interactions and remodeling of the tissue.

Introduction

Atherosclerosis is a disease of the vasculature with a complex etiology. Risk factors include age, sex, family history, dyslipidemia, high blood pressure and high body mass index (BMI), stress and dietary factors. The disease develops over a long time period and may remain asymptomatic over decades. It is characterized by chronic inflammation of the arterial wall, by infiltration of macrophages (MΦ) and accumulation of oxidized low-density lipoproteins leading to MΦ conversion to foam cells [1].

The vasculature is continuously exposed to cyclical fluctuations of blood flow, pressure and fluid shear stress and also exhibits diurnal variation. The blood mechanical impacts of varying magnitudes exert significant influences on physiological and pathophysiological processes [2], [3], [4]. For illustration, veins and arteries are composed of several tissue layers with different cell and extra-cellular matter (ECM) content. This cell and ECM composition determines the tissue characteristics in terms of physicochemical properties [5], [6]. Hence, each vessel layer possesses different ability to withstand, produce or transduce mechanical forces [5]. The mechanical pressure sensed by the endothelial cells is transferred from the extracellular space through the actin cytoskeletal network towards the nucleus [7], [8].

To date, a number of genes implicated in cellular mechanostability and their altered expression has been associated with the progress of atherosclerosis. For example, ADAM metalloprotease disintegrins have been linked with cell-cell/surface adhesion and inflammation progression in the atherosclerotic plaque [9]. Moreover, the expression levels of integrin and kindlin family proteins were found to be altered in progressing atherosclerotic plaques [10]. Intergrin and kindlin proteins support leukocyte adhesion, transendothelial migration, platelet aggregation and thrombosis. Furthermore, integrins and kindlins are together with talin and vinculin among the major components of focal adhesions (FA). FAs are key attachments between cells and ECM and play an important role in cell morphology, differentiation, locomotion and intercellular communication. FAs are crucial for the tissue remodeling, integrity and homeostasis through the maintenance of intercellular gaps and cell adhesion supervision.

Talin is a large flexible protein [11] binding to transmembrane integrins (N-terminal FERM domain) [12] and to cytoskeletal actin (C-terminal rod) [13] providing a vital link between the intra- and extracellular space and allowing the communication between the ECM and nucleus [8]. Talin plays a significant role in the actin filament assembly and in spreading and migration of various cell types. During the adhesion maturation, talin recruits vinculin to crosslink with F-actin filaments and stabilize the adhesion complex. For this purpose talin rod contains several binding sites for vinculin [14]. Vinculin binding sites (VBSs) are buried inside the structural bundles and require a major conformational change in the bundle organization prior to vinculin binding [15]. Mechanical force has been suspected to mediate such domain reorganization and talin-vinculin binding [16], [17]. Talin interacts with several ligands making it a vital component of numerous mechanosensor and chemical signaling pathways [18], [19], [20], [21].

Vinculin is a cytoskeletal protein crosslinking talin and F-actin. Vinculin is ubiquitously expressed with high expression in skeletal, cardiac and smooth muscle. Vinculin head at the N-terminal end binds to talin's VBSs [22]. Vinculin tail at the C-terminal end binds F-actin [23]. Also other important interactions of vinculin have been recognized, for example with paxilin [24] and α-actinin [25]. These ligands make vinculin an important contributor to focal adhesion complex, as well as to the cytoskeletal assembly and stability.

The progress and the causatives of atherosclerosis have been intensively investigated during the past decades. Still, the mechanisms behind the disease development are not fully understood. In more detail, the mechanical impact of shear stress on the cell and tissue integrity has risen to attention only recently. We hypothesize that the cellular mechanostability and maintenance of tissue integrity through focal adhesions is an important factor in all stages of atherosclerotic plaque development. We speculate that the function of focal adhesions is compromised by altered expression of cell adhesion proteins talin and vinculin in atherosclerotic plaque as compared to non-atherosclerotic vessel wall.

In this work, we followed talin and vinculin expression in atherosclerotic plaque samples collected in ongoing Tampere Vascular Study (TVS) series. Gene expression in carotid, abdominal aortic and femoral plaque samples was compared to expression values in left internal thoracic artery (LITA) controls. Expression levels were determined by microarray analysis and low-density qRT-PCR-array. Results are supported by smooth muscle cell (SMC) and macrophage (MΦ) marker co-expression analysis. The tissue localization of talin and vinculin was investigated by confocal immunofluorescence study.

Section snippets

Vascular samples

Arterial sample series from Tampere Vascular Study (TVS) [9], [10], [26], including samples from femoral, carotid and abdominal aortic regions, were obtained during open vascular procedures between 2005 and 2015. The patients fulfilled the following inclusion criteria: (1) carotid endarterectomy performed because of asymptomatic or symptomatic and hemodynamically significant carotid stenosis (>70%); (2) femoral or (3) aortic endarterectomy with aortoiliac or aortobifemoral bypass based on

Characteristics of the subjects and studied samples

The demographics and risk factors of studied population are presented in Table 1. All internal arteries used as controls were verified microscopically as normal. Body mass index, occurrence of hypercholesterolemia, high blood pressure, coronary artery disease and history of myocardial infarction differed significantly between control group and group with atherosclerotic plaques. For mononuclear and whole blood analysis, patients with coronary artery disease considered as case group differed

Discussion

In this study, we show for the first time that the gene expression of talin-1, talin-2, meta-vinculin and vinculin is significantly reduced in atherosclerotic plaques. Significant downregulation of expression was observed in all of the studied carotid, abdominal aortic and femoral arterial beds compared to LITA controls. However, expression of neither gene was changed in circulating monocytes or in whole blood samples in CAD patients compared to controls.

We speculate that reduction in talin-1

Conflict of interest

The authors declared they do not have anything to disclose regarding conflict of interest with respect to this manuscript.

Financial support

This work was supported by the Academy of Finland: grants 290506, 273192, 136288 (V.P.H), 286284 (T.L.), 285902 (E.R.), 134309; the Tampere University Hospital Medical Funds (grant X51001 (T.L), 9S054 (E.R) and X51410 (V.P.H)); the Finnish Foundation for Cardiovascular Research (T.L.); the Finnish Cultural Foundation (R.R.); the Tampere Tuberculosis Foundation (T.L. and N.O.); the Emil Aaltonen Foundation (T.L. and N.O.); and the Yrjö Jahnsson Foundation (T.L. and N.O.). This work was also

References (48)

  • M. Kroemker et al.

    Intramolecular interactions in vinculin control alpha-actinin binding to the vinculin head

    FEBS Lett.

    (1994)
  • E. Raitoharju et al.

    A comparison of the accuracy of Illumina HumanHT-12 v3 Expression BeadChip and TaqMan qRT-PCR gene expression results in patient samples from the Tampere Vascular Study

    Atherosclerosis

    (2013)
  • P.M. Kopp et al.

    Studies on the morphology and spreading of human endothelial cells define key inter- and intramolecular interactions for talin1

    Eur. J. Cell Biol.

    (2010)
  • S.J. Monkley et al.

    Endothelial cell talin1 is essential for embryonic angiogenesis

    Dev. Biol.

    (2011)
  • A.M. Manso et al.

    Talin1 has unique expression versus talin 2 in the heart and modifies the hypertrophic response to pressure overload

    J. Biol. Chem.

    (2013)
  • P.F. Davies

    Flow-mediated endothelial mechanotransduction

    Physiol. Rev.

    (1995)
  • W.C. Aird

    Endothelial cell heterogeneity

    Cold Spring Harb. Perspect. Med.

    (2012)
  • T.J. Chancellory et al.

    Actomyosin tension exerted on the nucleus through nesprin-1 connections influences endothelial cell adhesion, migration, and cyclic strain-induced reorientation

    Biophys. J.

    (2010)
  • Z. Jahed et al.

    Mechanotransduction pathways linking the extracellular matrix to the nucleus

    Int. Rev. Cell Mol. Biol.

    (2014)
  • N. Oksala et al.

    ADAM-9, ADAM-15, and ADAM-17 are upregulated in macrophages in advanced human atherosclerotic plaques in aorta and carotid and femoral arteries–Tampere vascular study

    Ann. Med.

    (2009)
  • J. Winkler et al.

    Energy-filtered electron microscopy reveals that talin is a highly flexible protein composed of a series of globular domains

    Eur. J. Biochem.

    (1997)
  • A.R. Gingras et al.

    The structure of the C-terminal actin-binding domain of talin

    EMBO J.

    (2008)
  • E. Papagrigoriou et al.

    Activation of a vinculin-binding site in the talin rod involves rearrangement of a five-helix bundle

    EMBO J.

    (2004)
  • V.P. Hytönen et al.

    How force might activate talin's vinculin binding sites: SMD reveals a structural mechanism

    PLoS Comput. Biol.

    (2008)
  • Cited by (0)

    1

    These authors contributed equally to this work.

    2

    These authors contributed equally to this work.

    View full text